|
SATB1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.856210E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.157900E-03 |
| Normal-vs-Stage2 |
1.401590E-01 |
| Normal-vs-Stage3 |
7.219000E-04 |
| Normal-vs-Stage4 |
2.392100E-04 |
| Stage1-vs-Stage2 |
8.369800E-01 |
| Stage1-vs-Stage3 |
1.556010E-01 |
| Stage1-vs-Stage4 |
1.954590E-01 |
| Stage2-vs-Stage3 |
2.023200E-01 |
| Stage2-vs-Stage4 |
1.754250E-01 |
| Stage3-vs-Stage4 |
6.976800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.121850E-03 |
| Normal-vs-AfricanAmerican |
2.806400E-02 |
| Normal-vs-Asian |
1.946010E-01 |
| Caucasian-vs-AfricanAmerican |
6.590600E-01 |
| Caucasian-vs-Asian |
7.403000E-01 |
| AfricanAmerican-vs-Asian |
5.768200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.016500E-04 |
| Normal-vs-Female |
3.549400E-01 |
| Male-vs-Female |
1.058600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.046200E-02 |
| Normal-vs-Extreme_Weight |
4.860600E-03 |
| Normal-vs-Obese |
6.818200E-03 |
| Normal-vs-Extreme_Obese |
8.512000E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.893600E-01 |
| Normal_Weight-vs-Obese |
7.731400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.719000E-01 |
| Extreme_Weight-vs-Obese |
7.315600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.806600E-01 |
| Obese-vs-Extreme_Obese |
6.918400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.341000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.615900E-02 |
| Normal-vs-Age(61-80Yrs) |
3.761100E-04 |
| Normal-vs-Age(81-100Yrs) |
5.773900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.326200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.561600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.326000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.909900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.061700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.734800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.172100E-02 |
| Normal-VS-Type2 PRCC |
2.98129999576346E-08 |
| Normal-VS-KIRP CIMP |
4.284000E-01 |
| Normal-VS-Unclassified PRCC |
6.548400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.84657999999782E-05 |
| Type1 PRCC-VS-KIRP CIMP |
9.298600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.659400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.643900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.563400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.429800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.71277999999608E-05 |
| Normal-vs-N1 |
1.765160E-04 |
| Normal-vs-N2 |
3.481600E-03 |
| N0-vs-N1 |
9.515800E-01 |
| N0-vs-N2 |
5.404400E-01 |
| N1-vs-N2 |
5.864200E-01 |
|
|
